Viewing StudyNCT00036257



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00036257
Status: COMPLETED
Last Update Posted: 2011-10-17
First Post: 2002-05-08

Brief Title: Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia
Sponsor: Astellas Pharma Inc
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Chronic Lymphocytic Leukemia
Keywords:
Name View
CLL View
Chronic Lymphocytic Leukemia View
Leukemia View